Artika Nath

Genomics Researcher | Baker Heart & Diabetes Institute and Cambridge Baker Systems Genomics Initiative
Honorary Fellow | University of Cambridge

[Artika Nath @natar210]

@moragjyoung Thanks,@moragjyoung for holding the fort since 2020. Massive congrats to Monika and @RXiang5. Very rewarding outcome.

[Artika Nath @natar210]

Very delighted to be part of this amazing work.

[Morag Young @moragjyoung]

We are super excited to have our work published and recognised by the media. Very many thanks to Drs Monica Kanki, Ruidong Xiang and Artika Nath, our coauthors and support from the BakerHDI for their hard work on this project. Now on to the next one….

[7NEWS Melbourne @7NewsMelbourne]

A Victorian-led study has finally pinpointed how much sleep we need each night. For more, @mikeamor7 spoke with Professor @moragjyoung from @BakerResearchAu. https://t.co/5zYfOfGqUb #7NEWS

[Artika Nath @natar210]

@minouye271 @IamYuXu Congrats @minouye271 and @IamYuXu glad to be part of this exciting work and great collaboration!!

[Rosa Pascual @RiustPascual]

Fantastic opportunity!🧬💻💊

[Artika Nath @natar210]

Proud moment for Fiji winning back-to-back gold at #TokyoOlympics, men's #Rugby. A small nation, yet very powerful.

[The Olympic Games @Olympics]

They've done it again!

A big congratulations to the #FIJ team on their second #gold in a row in the men’s #rugby sevens! 👏

#StrongerTogether | #Tokyo2020 | @WorldRugby | @fijirugby

[Artika Nath @natar210]

@D2Prakoso @DiabetesAus @rebeccahritchie @MilesDeBlasio Well Done, Darnel! Congrats to you and the group

[Erin Howden @erin_howden]

Whoa so proud to see this out in @CircAHA. Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension https://t.co/B3F2KykDlR Big team effort between @BakerResearchAu & @UZLeuven. @guido_claessen @minouye271 @ALaGerche

[EMBL-EBI @emblebi]

The polygenic risk score is an increasingly popular research tool with lots of potential in the clinical setting. See the minimal information framework developed by @PGSCatalog & collaborators to promote the validity, transparency & reproducibility of data
https://t.co/NDRkbSvxOf

[Baker Institute @BakerResearchAu]

Out now: We show how genetics is being used to aid risk prediction, diagnosis & earlier treatment of diseases such as juvenile arthritis. It follows development of genomic risk scores for coronary artery disease & ischaemic stroke @minouye271 @rcanovas2 https://t.co/Gc5VfTPlum

[Rodrigo Canovas @rcanovas2]

Our work shows the potential of GRSs for JIA as a composite diagnosis as well as the subtype-specific GRSs. It also suggests that a diagnostic algorithm based on a JIA-GRS may provide a more timely, accessible and reliable means of assessing children with JIA. 6/7

[Baker Institute @BakerResearchAu]

Very exciting news, thank you @NCInews and @PawseyCentre. More detail about the Baker Institute grant here https://t.co/andTDvqNCe

[Professor Gordon Dougan FRS @GordonDougan1]

Find our new blog post ‘How to make a COVID-19 vaccine from scratch’ written with @DrKatHolt. Aimed at vaccine non-experts, students, journalists etc. Covers all aspects of vaccine development from start to finish. All in one place. Enjoy!
https://t.co/P21rR46MhV

[Brian G. Drew 🇦🇺👨‍🔬 @briandrew101]

Question @ScottMorrisonMP @DanielAndrewsMP. How are our gas, electricity and internet providers contributing to reducing the burden of #covid19australia ? We’re all working from home, they’re all reaping the benefits!

[Artika Nath @natar210]

Latest from @minouye271's lab @BakerResearchAu @CamBakerSGI, led by @YigoKairos & @GadAbraham1 - A GRS for Juvenile Arthritis may pave the way to early diagnosis (particularly for some subtypes)

[Rodrigo Canovas @YigoKairos]

New preprint! Genomic risk scores for juvenile idiopathic arthritis and its subtypes. These JIA GRSs hold promise for rapid clinical translation with at-risk children as high risk much earlier in the diagnostic pathway.
https://t.co/j80JzLcNA7 @medrxivpreprint

[Rodrigo Canovas @YigoKairos]

New preprint! Genomic risk scores for juvenile idiopathic arthritis and its subtypes. These JIA GRSs hold promise for rapid clinical translation with at-risk children as high risk much earlier in the diagnostic pathway.
https://t.co/j80JzLcNA7 @medrxivpreprint

[Artika Nath @natar210]

@minouye271 @BakerResearchAu @GadAbraham1 Thanks for correcting @minouye271

[Artika Nath @natar210]

Two @BakerResearchAu awards for @minouye271's lab- Happy to receive the Baker Quarterly research prize for excellence with @Gad – for our latest publications on Multivariate Cytokine GWAS https://t.co/3uEYJCSHv5 a PRS for Stroke https://t.co/3VMlwECLuf

[Chris Wallace 🇪🇺 🏳️‍🌈 @chr1swallace]

By reducing the genome to a radically few 13 immune-focused dimensions, we perform comparative study of the genetics of rare and common immune-mediated diseases, and identify biological co-factors for specific disease clusters, work led by @ollyburren https://t.co/2gLDo4kSWm